US Patent and Trademark Office Grants Patent to Ventegra for Its Acquisition Cost Index (ACI) Cost-Plus Pricing Reimbursement Technology Platform for Prescription Drugs
GLENDALE, Calif.–(BUSINESS WIRE)–The US Patent and Trademark Office (USPTO) has granted US patent number 11,023,979 B2 (June 1, 2021) that covers Ventegra’s Acquisition Cost Index (ACI) cost-based reimbursement technology (Reference Price Index) through 2034. Ventegra, a leader in transparent, cost-plus pricing methodology, is a new class-of-trade Medical Benefit Manager (MBM) that manages healthcare costs to […]


